Trial
NCT00881595
Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Florida
Collaborators
—
Condition
Soft Tissue Sarcomas
Intervention
Chemoradiotherapy Temozolomide
Why stopped
No patients accrued since study opened
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-10